Plasma Angiopoietin-2 Predicts the Onset of Acute Lung Injury in Critically Ill Patients
- 1 April 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 187 (7) , 736-742
Abstract
Rationale: Current clinical prediction scores for acute lung injury (ALI) have limited positive predictive value. No studies have evaluated predictive plasma biomarkers in a broad population of critically ill patients or as an adjunct to clinical prediction scores. Objectives: To determine whether plasma angiopoietin-2 (Ang-2), von Willebrand factor (vWF), interleukin-8 (IL-8), and/or receptor for advanced glycation end products (sRAGE) predict ALI in critically ill patients. Methods: Plasma samples were drawn from critically ill patients (n = 230) identified in the emergency department. Patients who had ALI at baseline or in the subsequent 6 hours were excluded, and the remaining patients were followed for development of ALI. Measurements and Main Results: Nineteen patients developed ALI at least 6 hours after the sample draw. Higher levels of Ang-2 and IL-8 were significantly associated with increased development of ALI (P = 0.0008, 0.004, respectively). The association between Ang-2 and subsequent development of ALI was robust to adjustment for sepsis and vasopressor use. Ang-2 and the Lung Injury Prediction Score each independently discriminated well between those who developed ALI and those who did not (area under the receiver operating characteristic curve, 0.74 for each), and using the two together improved the area under the curve to 0.84 (vs. 0.74, P = 0.05). In contrast, plasma levels of sRAGE and vWF were not predictive of ALI. Conclusions: Plasma biomarkers such as Ang-2 can improve clinical prediction scores and identify patients at high risk for ALI. In addition, the early rise of Ang-2 emphasizes the importance of endothelial injury in the early pathogenesis of ALI.Keywords
This publication has 40 references indexed in Scilit:
- Plasma angiopoietin-2 in clinical acute lung injuryCritical Care Medicine, 2012
- Biomarkers in Acute Lung Injury—Marking Forward ProgressCritical Care Clinics, 2011
- Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injuryCritical Care Medicine, 2011
- Early Identification of Patients at Risk of Acute Lung Injury: Evaluation of Lung Injury Prediction Score in a Multicenter Cohort StudyAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Beyond Mortality: Future Clinical Research in Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Acute Lung Injury in Patients With Traumatic Injuries: Utility of a Panel of Biomarkers for Diagnosis and PathogenesisJournal of Trauma: Injury, Infection & Critical Care, 2010
- Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the EndotheliumMolecular and Cellular Biology, 2009
- Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injuryThorax, 2008
- Plasma Receptor for Advanced Glycation End-products Predicts Duration of ICU Stay and Mechanical Ventilation in Patients After Lung TransplantationThe Journal of Heart and Lung Transplantation, 2007
- Hyperoxia causes angiopoietin 2–mediated acute lung injury and necrotic cell deathNature Medicine, 2006